LEGN
Legend Biotech Corporation
NASDAQ · Healthcare · Biotechnology · US
$21.57
−0.83%Margins
Gross margin
56.6%
EBITDA margin
-0.6%
EBIT margin
-4.4%
Net margin
-7.2%
FCF margin
-20.1%
-7.4%
Return on equity
-5.2%
Return on assets
-3.7%
Return on invested capital
0.76x
Asset turnover
-$183.1M
Cash from operations
$4.96
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026